Observations on the cognitive behavioral treatment of panic disorder: Impact of benzodiazepines

W. C. Sanderson, Scott Wetzler

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Multi-modal treatment using CBT plus benzodiazepines is a common approach for PD. A survey of two anxiety disorder clinics revealed that approximately one-half of all PD patients receive combined treatment (usually CBT plus alprazolam). In fact, this strategy is the recommended treatment of choice, according to several recent publications. The rationale for such a treatment is that benzodiazepines help to decrease anxiety and panic in the short run, making the patient amenable to psychotherapy, while CBT offers a long-term solution for coping with panic. Despite this line of reasoning, in our clinical experience, we find that the concomitant use of benzodiazepines throughout the course of CBT has an adverse effect on the psychotherapy. Benzodiazepines interfere with the basic mechanism of action of CBT. For CBT to be effective, anxiety must be elicited under the controlled circumstances of the therapy. It is only through the evocation of anxiety that useful coping skills may be established. Unfortunately, benzodiazepines prevent the evocation of anxiety during treatment, and there is less opportunity to develop effective coping skills. Moreover, anxiolytic effects are then attributed to the medication and not to psychotherapeutic growth which will remain with the patient after the medication has been discontinued.

Original languageEnglish (US)
Pages (from-to)125-132
Number of pages8
JournalPsychotherapy
Volume30
Issue number1
StatePublished - 1993

Fingerprint

Panic Disorder
Benzodiazepines
Anxiety
Panic
Psychological Adaptation
Psychotherapy
Therapeutics
Alprazolam
Anti-Anxiety Agents
Anxiety Disorders
Growth

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Observations on the cognitive behavioral treatment of panic disorder : Impact of benzodiazepines. / Sanderson, W. C.; Wetzler, Scott.

In: Psychotherapy, Vol. 30, No. 1, 1993, p. 125-132.

Research output: Contribution to journalArticle

@article{ceae1ee932ff43fbafc360daec4e6637,
title = "Observations on the cognitive behavioral treatment of panic disorder: Impact of benzodiazepines",
abstract = "Multi-modal treatment using CBT plus benzodiazepines is a common approach for PD. A survey of two anxiety disorder clinics revealed that approximately one-half of all PD patients receive combined treatment (usually CBT plus alprazolam). In fact, this strategy is the recommended treatment of choice, according to several recent publications. The rationale for such a treatment is that benzodiazepines help to decrease anxiety and panic in the short run, making the patient amenable to psychotherapy, while CBT offers a long-term solution for coping with panic. Despite this line of reasoning, in our clinical experience, we find that the concomitant use of benzodiazepines throughout the course of CBT has an adverse effect on the psychotherapy. Benzodiazepines interfere with the basic mechanism of action of CBT. For CBT to be effective, anxiety must be elicited under the controlled circumstances of the therapy. It is only through the evocation of anxiety that useful coping skills may be established. Unfortunately, benzodiazepines prevent the evocation of anxiety during treatment, and there is less opportunity to develop effective coping skills. Moreover, anxiolytic effects are then attributed to the medication and not to psychotherapeutic growth which will remain with the patient after the medication has been discontinued.",
author = "Sanderson, {W. C.} and Scott Wetzler",
year = "1993",
language = "English (US)",
volume = "30",
pages = "125--132",
journal = "Psychotherapy",
issn = "0033-3204",
publisher = "American Psychological Association Inc.",
number = "1",

}

TY - JOUR

T1 - Observations on the cognitive behavioral treatment of panic disorder

T2 - Impact of benzodiazepines

AU - Sanderson, W. C.

AU - Wetzler, Scott

PY - 1993

Y1 - 1993

N2 - Multi-modal treatment using CBT plus benzodiazepines is a common approach for PD. A survey of two anxiety disorder clinics revealed that approximately one-half of all PD patients receive combined treatment (usually CBT plus alprazolam). In fact, this strategy is the recommended treatment of choice, according to several recent publications. The rationale for such a treatment is that benzodiazepines help to decrease anxiety and panic in the short run, making the patient amenable to psychotherapy, while CBT offers a long-term solution for coping with panic. Despite this line of reasoning, in our clinical experience, we find that the concomitant use of benzodiazepines throughout the course of CBT has an adverse effect on the psychotherapy. Benzodiazepines interfere with the basic mechanism of action of CBT. For CBT to be effective, anxiety must be elicited under the controlled circumstances of the therapy. It is only through the evocation of anxiety that useful coping skills may be established. Unfortunately, benzodiazepines prevent the evocation of anxiety during treatment, and there is less opportunity to develop effective coping skills. Moreover, anxiolytic effects are then attributed to the medication and not to psychotherapeutic growth which will remain with the patient after the medication has been discontinued.

AB - Multi-modal treatment using CBT plus benzodiazepines is a common approach for PD. A survey of two anxiety disorder clinics revealed that approximately one-half of all PD patients receive combined treatment (usually CBT plus alprazolam). In fact, this strategy is the recommended treatment of choice, according to several recent publications. The rationale for such a treatment is that benzodiazepines help to decrease anxiety and panic in the short run, making the patient amenable to psychotherapy, while CBT offers a long-term solution for coping with panic. Despite this line of reasoning, in our clinical experience, we find that the concomitant use of benzodiazepines throughout the course of CBT has an adverse effect on the psychotherapy. Benzodiazepines interfere with the basic mechanism of action of CBT. For CBT to be effective, anxiety must be elicited under the controlled circumstances of the therapy. It is only through the evocation of anxiety that useful coping skills may be established. Unfortunately, benzodiazepines prevent the evocation of anxiety during treatment, and there is less opportunity to develop effective coping skills. Moreover, anxiolytic effects are then attributed to the medication and not to psychotherapeutic growth which will remain with the patient after the medication has been discontinued.

UR - http://www.scopus.com/inward/record.url?scp=0027762433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027762433&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027762433

VL - 30

SP - 125

EP - 132

JO - Psychotherapy

JF - Psychotherapy

SN - 0033-3204

IS - 1

ER -